Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

New treatment discovered for heart tissue scarring after infarct

Jan. 9, 2020

Cytokinetics initiates phase II trial of CK-3773274 for hypertrophic cardiomyopathy

Jan. 7, 2020

Anthos Therapeutics studies MAA-868 in phase II for atrial fibrillation

Dec. 31, 2019

Quantum Genomics begins phase III study of firibastat in hypertension

Dec. 23, 2019

FDA approves IND for phase I trial of TransThera's TT-00920 for heart failure

Dec. 18, 2019

FDA approves Vascepa to reduce cardiovascular risk in adults with elevated triglyceride levels

Dec. 16, 2019

Sunshine Lake Pharma discloses mineralocorticoid receptor antagonists

Dec. 9, 2019

Development of preclinical canine models for pharmacological studies of AF

Dec. 5, 2019

Kancera presents data from in-depth analysis of KAN-D567 phase Ib program

Dec. 5, 2019

First patient dosed in phase II study of zilucoplan for the treatment of IMNM

Dec. 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...